PNPLA3 and metabolic dysfunction-associated steatohepatitis: In conclusion, these observations emphasize that PNPLA3 expression in human biopsies is closely linked with HSCs activation and liver fibrosis progression in NASH livers, being metabolically controlled by glucose and pro‐steatotic conditions.